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Mental retardation (MR) is the most frequent handicap among children and young adults. Although a large proportion of X-linked MR
genes have been identiﬁed, only four genes responsible for autosomal-recessive nonsyndromic MR (AR-NSMR) have been described so
far. Here, we report on two genes involved in autosomal-recessive and X-linked NSMR. First, autozygosity mapping in two sibs born to
ﬁrst-cousin French parents led to the identiﬁcation of a region on 8p22-p23.1. This interval encompasses the geneN33/TUSC3 encoding
one subunit of the oligosaccharyltransferase (OTase) complex, which catalyzes the transfer of an oligosaccharide chain on nascent pro-
teins, the key step of N-glycosylation. Sequencing N33/TUSC3 identiﬁed a 1 bp insertion, c.787_788insC, resulting in a premature stop
codon, p.N263fsX300, and leading to mRNA decay. Surprisingly, glycosylation analyses of patient ﬁbroblasts showed normal N-glycan
synthesis and transfer, suggesting that normal N-glycosylation observed in patient ﬁbroblasts may be due to functional compensation.
Subsequently, screening of the X-linked N33/TUSC3 paralog, the IAP gene, identiﬁed a missense mutation (c.932T/G, p.V311G) in
a family with X-linked NSMR. Recent studies of fucosylation and polysialic-acid modiﬁcation of neuronal cell-adhesion glycoproteins
have shown the critical role of glycosylation in synaptic plasticity. However, our data provide the ﬁrst demonstration that a defect in
N-glycosylation can result in NSMR. Together, our results demonstrate that ﬁne regulation of OTase activity is essential for normal
cognitive-function development, providing therefore further insights to understand the pathophysiological bases of MR.Introduction
Mental retardation (MR), deﬁned as an intelligence quo-
tient below 70, is the most frequent handicap in children,
affecting 1% to 3% of the general population.1 Despite
recent advances, the causes of nearly 40% of MR remain
unclear. Although a considerable number of X-linked MR
(XLMR) genes are known, only four genes causing auto-
somal-recessive nonsyndromic MR (AR-NSMR) have been
identiﬁed so far: PRSS12 (MIM 606709),2 CRBN (MIM
609262),3 CC2D1A (MIM 610055),4 and GRIK2 (MIM
138244).5 These genes are involved in different pathways,
namely synaptic proteolysis, regulation of mitochondrial
energy metabolism, regulation of I-kB kinase/NF-kB
cascade, and induction of long-term potentiation (LTP),
underlining the extreme heterogeneity of the pathophysi-
ological mechanism involved in these diseases.
Glycosylation is an important posttranslationalmodiﬁca-
tion that occurs in every cell and has a signiﬁcant impact
on numerous biological processes. Many defects in the
asparagine-linked glycosylation (N-glycosylation) have
been identiﬁed in congenital disorders of glycosylation
(CDG) syndromes.6,7 Their diagnosis is based on the identi-
ﬁcation of underglycosylated transferrin, either by
isoelectric focusing or mass-spectrometry analyses. Clini-
cally, CDG syndromes are characterized by psychomotor re-1150 The American Journal of Human Genetics 82, 1150–1157, Maytardation, ataxia, failure to thrive, dysmorphic features, and
coagulopathies. To date, 18 different CDG subtypes have
been described: 12 types in group I CDG and six in group
II. Group I CDG results in the disrupted synthesis of the oli-
gosaccharide chain, whereas group II CDG is deﬁned as
defects in the processing of the protein-bound glycan.6 In
eukaryotic cells, the key step of the N-glycosylation is medi-
ated by the oligosaccharyltransferase (OTase), an oligomeric
membrane-protein complex that catalyzes the transfer of
preassembled high-mannose oligosaccharide onto aspara-
gine residues of nascent polypeptides entering the lumen
of the endoplasmic reticulum.8 There are at least two mam-
malian OTase complexes that differ by the presence of N33/
TUSC3(MIM601385)or IAP.Thesecomplexesarecomposed
of sevenproteins:Ribophorin I (MIM180470),Ribophorin II
(MIM180490),OST48 (MIM602202),DAD1 (MIM600243),
STT3A/B (MIM601134,MIM608605),OST4 (MIM604059),
andN33/TUSC3 or IAP,8 and, to date, nomutation in any of
these subunitshaseverbeenhighlighted inahumandisease.
In this article, we show that mutations in two OTase-
subunit genes, N33/TUSC3 and IAP (also named MAGT1),
the Ost3 and Ost6 Saccharomyces cerevisae human ortho-
logs, respectively, result in NSMR. These data expand the
spectrum of the CDG syndromes and emphasize the cru-
cial role of glycosylation activity in higher brain functions
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Material and Methods
Subjects and Families
Family 1
Affected children are 32 and 25 yr old, respectively. In both cases,
pregnancy and delivery were uneventful (patient V.1: length 47
cm, weight 3050 g, head circumference 35.5 cm; patient V.4:
length 49 cm, weight 3400 g, head circumference 35 cm), and
no postnatal infection, toxic exposure, or signiﬁcant head trauma
was noted. Standard assessment revealed signiﬁcant developmen-
tal delay in the two sibs (independent walking at 3 and 2.5 yr,
respectively; no speech at 3 and 4 yr, respectively). Mental
retardation could be estimated as severe and appeared nonpro-
gressive.
Figure 1. Genetic Analysis of Family 1
(A) Pedigree of family 1. The black symbols
indicate the affected individuals. Auto-
zygosity mapping was performed with Affy-
metrix GeneChip Human Mapping 10K for
individuals IV.3, IV.4, and V.1 to V.4. Hap-
lotypes are shown beneath each genotyped
individual. Markers are from telomere to
centromere, and their positions, based on
the UCSC Genome browser, are indicated
in bp.
(B) Electropherograms of N33/TUSC3
exon 6 in an affected patient (left) and
a control (right). DNA sequencing identi-
fied a one base-pair homozygous insertion
c.787_788insC.
(C) N33/TUSC3 mutation and phylogenetic
analysis of N33/TUSC3 proteins in various
species. Amino acids are in italics; bold
and underlined indicate the frame shift
caused by N33/TUSC3 mutation.
Physical examination of both patients at
31 and 24 yr of age was unremarkable,
with normal height, weight, and head cir-
cumference. Examination showed no mal-
formations andnormalmetabolic screening
(amino acid chromatography, blood lactate
and pyruvate levels, liver function, and am-
monemia).Molecular testing ruled out frag-
ile X syndrome. High-resolution chromo-
some analysis, bone X-rays, cerebral MRI,
and electroencephalogramwere all normal.
Family 2
In this sibship of ﬁve children (one healthy
girl, two girls with mild MR, and two boys
with severe MR), only one affected boy
(III.5, 62 yr old) is still alive; the other af-
fected individuals (III.6) are deceasedof liver
or cervical cancer. The two affected males
had a similar phenotype with the same de-
gree of handicap. Both were in educational
classes for the moderately handicapped.
They were both able to hold a limited con-
versation; neither learned to read or write. Both were on disability
pensions as adults. III.5 is in protected employment in a gardening
team, andhe lives independently and cooks his ownmeals but is vis-
itedvery regularlybyhis sister,whosuperviseshis affairs.When59yr
old, he hadnormal growthparameters (height 166 cm;head circum-
ference 57 cm). Their mother (II.2) was described as slow. One sister
(III.4) who is deceased was in a special class for the mildly handi-
capped at school but was not as slow as the brothers.
Microarray Analysis
The 10K Array contains 11,555 single-nucleotide polymorphisms
(SNPs) covering the whole human genome with a mean genetic
map distance of 0.32 cM. The average distance between the
SNPs is 210 kb, and the average heterozygosity of these SNPs isThe American Journal of Human Genetics 82, 1150–1157, May 2008 1151
0.37. According to the manufacturer’s instructions, 250 ng total
genomic DNA was digested with a restriction enzyme (XbaI) and
ligated to adaptors that recognize the cohesive 4 bp overhangs.
Ampliﬁcation, puriﬁcation, labeling, and hybridization of PCR
products were performed as recommended by the manufacturer.
Results were analyzed with the GeneChip DNA Analysis software
3.0 (GDAS 3.0), and parametric linkage analyses were subse-
quently done with the Merlin program.
Mutation Screening of the N33/TUSC3 and IAP Genes
Blood samples were obtained from siblings and their parents of
family 1 after informed consent, and genomic DNA was isolated
from blood leucocytes with the Nucleon kit (Amersham) accord-
ing to the manufacturer’s instructions. Genomic DNA from family
2 probands was isolated, after informed consent, from a lympho-
blastoid cell line (patient III.5), from a Guthrie test sample (patient
III.6), and from blood samples (patient III.2, III.3, IV.1, IV.2, and
IV.3). Speciﬁc primers for PCR ampliﬁcation of exons and splicing
junctions of N33/TUSC3 and IAP were designed on the basis of
their sequence data from the GenBank database (NT_030737
and NT_113965, primer sequences are available on request). PCR
products were puriﬁed with Exo-SAP (Amersham) and directly
sequenced on an automated sequencer (ABI 3130xl, Applied
Biosystems) via the dye-terminator method.
Expression Analyses of the N33/TUSC3
and IAP Genes by RT-PCR
Selected RNAs from the Total Human RNA Master Panel II (Clon-
tech) were subjected to reverse transcription with the SuperScript
First-Strand Synthesis System (Invitrogen). Speciﬁc primers for
PCR ampliﬁcation of N33/TUSC3, IAP, and Vimentin (Vim) mRNA
were designed on the basis of their sequence data from the Gen-
Bank database (NM_178234, NM_032121, and BC000163 respec-
tively,): N33/TUSC3, forward 50-GTTCTGTGTGCAGGCAAGCT
A-30 and reverse 50-GGATAGCCGTGGTACTTGG-30; IAP, forward
50-CGTCATGTTCACTGCTCTCC-30 and reverse 50-CGAAGATACA
CAAGTCCACC-30; and Vim, forward 50-ACCAGCTAACCAACG
ACAAA-30 and reverse 50-TGCTGTTCCTGAATCTGAGC-30.
Quantitative Real-Time RT-PCR
The level of N33/TUSC3, Vimentin (Vim), and Beta-actin (ACTB)
mRNA expression were studied with speciﬁc primers designed ac-
cording to GenBank sequence database: N33/TUSC3, forward 50-G
Figure 2. Quantitative PCR Analysis of
N33/TUSC3 mRNA
N33/TUSC3 expression in fibroblasts from
two controls (black and white bars) and pa-
tient V.1 (gray bar). Data are normalized to
Beta-actin (ACTB) or Vimentin (Vim). Means
are given5 standard deviation (n¼ 4 to 8
independent RT-PCR). ***, p < 0.001 as
compared to controls, Student’s t test.
AACGGATGTTCATATTCGGGT-30 and re-
verse 30-CGCTTAAAGCAAACCTCCAACA
A-50; Vim, forward 50-ACCAGCTAACCAA
CGACAAA-30 and reverse 50-TGCTGTTCC
TGAATCTGAGC-30; and ACTB, forward
50-AGATCAAGATCATTGCTCCTCC-30 and
reverse 50-AAAACAAATAAAGCCATGCCAATCT-30. The quantita-
tive assays were set up with the Light Cycler system with FastStart
DNAMasterPLUS SYBRGreen I (Roche). PCRswereperformedwith5
ml of diluted cDNA template, forward and reverse primers (5 pmol
each), and SYBR Green MasterPLUS Mix (4 ml) at a ﬁnal volume of
20 ml. Each reaction was performed at an annealing temperature
of 60C and for 40 cycles. Melting-curve analysis was performed
to assess the speciﬁcity of each transcript ampliﬁed. All reactions
were performed in duplicate. For each ampliﬁcation, a standard
calibration using a control cDNA with different dilutions was per-
formed. Relative expression was assessed with the calculated
concentration in respect to the standard, so that a ratio of 1 repre-
sents an average ratio between N33/TUSC3 mRNA and Vim or
ACTBmRNA in control samples.
Cell Culture
Primary ﬁbroblasts from patients and controls were cultured at
37C under 5% CO2 in RPMI 1640/Glutamax (Invitrogen) supple-
mented with 10% of fetal calf serum (Invitrogen).
Release of the N-Linked Oligosaccharides and Clean-
Up Procedure of the PNGase F-Released N-Glycans
Twenty microliters of serum were dried in a vacuum centrifuge.
The N-glycans were released and puriﬁed as previously described.9
Permethylation of the Glycans and MALDI-TOF-MS
Permethylation of the freeze-dried glycans and MALDI-TOF-MS
analyses of permethylated glycans were performed as described
elsewhere.9
Metabolic Labeling with [2-3H]mannose and
[35S]methionine
Fibroblasts (5 3 105 cells/well) were grown in DMEM supple-
mented with 10% of fetal calf serum. The next day, cells were met-
abolically labeled for 20, 40, and 60min, respectively, inMEM free
of methionine and cysteine, supplemented with 16 mCi/ml
[2-3H]mannose and 5 mCi/ml [35S]methionine per well. Cells
were then washed twice with ice-cold phosphate-buffered saline
(PBS; pH 7.4) and scrapped into 1 ml of CHCl3/MeOH/H20 (1/2/
2 v/v). The proteins were extracted and resuspended in 1% SDS.
Radioactivity incorporated was determined by liquid scintillation
counting.1152 The American Journal of Human Genetics 82, 1150–1157, May 2008
Results
Linkage Analysis of Family 1
We had the opportunity to study two sibs born to second-
cousin French parents (family 1, Figure 1A) and presenting
NSMR. Autozygosity mapping, with the Affymetrix Gene-
Chip Human Mapping 10K array, in both affected and
healthy children and in parents identiﬁed a unique
homozygous region on chromosome 8p22-p23.1
(Figure 1A). Further polymorphic marker analyses reduced
the critical region to an 8 Mb interval (maximum LOD
Figure 3. MALDI-TOF MS Analysis of
Total Human Serum N-Glycome
(A) Spectrum obtained from of a normal
individual.
(B and C) Spectra obtained from the two af-
fected children of family 1, V.4 and V.1, re-
spectively. Only the structures of the major
N-glycans are given. A minor portion of the
monofucosylated glycans carries fucose on
an antenna rather than the core. Galactose
(open circles), mannose (closed circles),
GlcNAc (closed squares), fucose (open tri-
angles), and NeuAc (closed diamonds) are
shown.
(D) Incorporation of [2-3H]mannose and
[35S]methionine was determined after met-
abolic labeling of fibroblasts for 20, 40,
and 60 min. Shown is the average ratio of
[35S]methionine versus [2-3H]mannose in-
corporation into proteins of two indepen-
dent experiments.
score Zmax ¼ 2.65 at q ¼ 0 for marker
D8S552) encompassing 25 known
genes and a dozen predicted genes.
On the basis of their expression in
the brain and their putative role in
the central nervous system (CNS),
four genes were sequenced (TNKS
[MIM 603303], FDFT1 [MIM
184420], NEIL2 [MIM 608933], and
SOX7), and then N33/TUSC3 (Ost3
Saccharomyces cerevisae ortholog)
was. The N33/TUSC3 transcription
unit encompasses 11 exons and en-
codes two isoforms (1 and 2) sharing
the ﬁrst nine exons but containing
a distinct 30 exon. This alternative
splicing results in the synthesis of
two proteins differing by their ﬁve
C-terminal amino acids.
Direct sequencing of all coding
exons and exon-intron junctions
identiﬁed a 1 bp homozygous inser-
tion in exon 6, c.787_788insC
(Figure 1B). This frameshift mutation
(p.N263fsX300) cosegregated with the disease and was pre-
dicted to cause the premature termination of translation
and the synthesis of a truncated N33/TUSC3 protein lack-
ing the 84 C-terminal amino acids (Figure 1C). This variant
was not found in 250 control chromosomes from various
ethnic origins (90% of European descent, 10% North Afri-
can).
Functional Analysis of N33 Mutation
The consequence of the c.787_788insC sequence variant on
N33/TUSC3 expressionwas assessedby reverse-transcriptionThe American Journal of Human Genetics 82, 1150–1157, May 2008 1153
PCR (RT-PCR) of cultured skin ﬁbroblast RNAs of patient
V.1. No aberrant mRNA but a reduced amount of transcript
was observed. Quantitative real-time RT-PCR (qRT-PCR)
with the Light Cycler technology showed a signiﬁcantly re-
duced amount of N33/TUSC3 mRNA in patient V.1 ﬁbro-
blasts as compared to two controls for which two house-
keeping genes were used (from 54.1% to 79.1% of
reduction, p < 0.001, Figure 2). These results suggest that
the primary effect of this frameshift mutation is non-
sense-mediated decay of the N33/TUSC3 mRNA.
Glycosylation Analysis in Cells Harboring
the N33 Mutation
Because isoelectric focusing showed no alteration of se-
rum-transferrin glycosylation (data not shown), we under-
took the mass-spectrometry characterization of N-glycan
structures of glycoproteins isolated from the patient’s se-
Figure 4. Genetic Analysis of Family 2
(A) Pedigree of family 2. The black symbols
indicate individuals presenting severe MR,
the white and black symbols indicate
individuals presenting mild MR, and the
white symbols indicate the nonaffected
individuals. Carriers of mutated (mut) or
wild-type (wt) alleles are indicated.
(B) Electropherograms of IAP exon 9 in one
affected boy of family 2 (left) and a control
(right). DNA sequencing identified a mis-
sense mutation c.932T/G.
(C) IAP mutation and phylogenetic
analysis of IAP proteins in various spe-
cies. The arrow and bold amino acids
indicate the substitution caused by the
mutation.
rum.10 The MALDI-TOF spectra of
permethylated N-glycans obtained
by deglycosylation of serum glyco-
proteins of patients V.1 and V.4 were
compared to a control serum sample
(Figures 3A–3C). A total of 26 oligo-
saccharide structures were individual-
ized, but neither qualitative nor
quantitative differences were ob-
served. This result suggests that the
N33/TUSC3mutation had no overt ef-
fect on the glycosylation pattern of
serum proteins but probably affected
speciﬁc cell types. To further investi-
gate whether N33/TUSC3 subunit
mutation could alter glycan transfer,
we compared the incorporation of
[2-3H]mannose into nascent proteins
in control and patient cells. After met-
abolic labeling, the ratio of [35S]me-
thionine/[2-3H]mannose was similar
in patient and control ﬁbroblasts (Figure 3D), suggesting
that the N33/TUSC3mutation did not lead to global N-gly-
can transfer impairment.
Mutation Screening of N33 Paralog, the IAP Gene
The OTase subunit Ost3p and its paralog Ost6p have been
originally identiﬁed in yeast.11,12 They share 20% of
sequence identity and display a strikingly similar mem-
brane topology. In addition to the N33/TUSC3 gene, mam-
malian genomes also contain anOst6 ortholog, named IAP,
which maps to Xq21.1 and composed of ten coding exons.
We therefore investigated whether IAP gene mutations
could account for MR. We ﬁrst sequenced all coding exons
and exon-intron junctions in a series of 18 probands in
XLMR families linked to the Xq21.1 region, and no muta-
tion was found. Then, we took advantage of the Interna-
tional Genetics of Learning Disabilities program, which1154 The American Journal of Human Genetics 82, 1150–1157, May 2008
undertook a systematic, high-throughput mutational
screen of the VEGA-annotated X chromosome gene set
(737 genes) in 250 MR families.13 One proband per family
had been previously tested for karyotype anomalies, FMR1
Figure 5. Expression Analyses of N33/
TUSC3, IAP, and Vimentin
Expression was asseyed by RT-PCR on adult
and fetal total RNA isolated from various
tissues (Clontech): fetal liver (F.liv), heart,
kidney (Kid.), adult liver (Ad.liv), lung,
placenta (Pl.), prostate (Pr.), salivary
gland (Sal.g), skeletal muscle (Sk.m), tes-
tis, thymus, thyroid gland (Thyr.g), tra-
chea (Tr.), uterus (Ut.), fetal chondrocytes
(F.ch), and osteoblasts (Ost.). Amplicon
length of N33/TUSC3, IAP, and Vimentin
(Vim) are indicated in bp.
Figure 6. Expression Analyses of N33/
TUSC3, IAP, and Vimentin (Vim) mRNAs
in Adult and Fetal Brain Structures
Expression was tested by RT-PCR on adult
and fetal structures (Clontech): adrenal
gland (Adr.g), bone marrow (B.m), cerebel-
lum (Cer.), adult brain (Ad.brain), fetal
brain (F.brain), spinal cord (Sp.c), hippo-
campus (Hipp.), and cortex (Cx). Amplicon
length of N33/TUSC3, IAP, and Vimentin
(Vim) are indicated in bp.
mutations, and mutations in the 61
known XLMR genes. Samples were
then subsequently screened for vari-
ants in coding exons and splice junc-
tions of the remaining 737 VEGA-an-
notated X chromosome genes (Vega
Genome Browser) by bidirectional,
PCR-based direct sequencing. A single
variant in the IAP gene was identiﬁed
in the proband of an Australian fam-
ily (c.932T/G, p.V311G; family 2,
Figure 4B). The p.V311G variant cose-
gregated with the disease (Figure 4A)
and involved a highly conserved
amino acid (Figure 4C). This variant
was not found in 267 control X chro-
mosomes. Neither N33/TUSC3 nor
IAP mRNA was expressed in lymphoblastoid cell lines,
and no skin ﬁbroblasts from this patient were available,
ruling out the possibility of testing the impact of this mu-
tation at the RNA level.The American Journal of Human Genetics 82, 1150–1157, May 2008 1155
Tissue Distribution of N33 and IAP mRNA
To get further insight in the functional consequences of
theN33/TUSC3 and IAPmutations, we undertook the anal-
ysis of their expression by RT-PCR in various adult and fetal
tissues. As shown in Figure 5, both genes were found
ubiquitously expressed, including in fetal and adult brain
structures tested (Figure 6A). Noticeably, N33/TUSC3
expression was found more abundant in total fetal brain
(Figure 6A).
Discussion
Surprisingly, although the OTase complex plays a key role
in N-glycosylation, no OTase subunit mutations have been
hitherto identiﬁed in human. To our knowledge, our data
provide the ﬁrst demonstration that mutations in OTase
subunits are responsible for isolated cognitive deﬁcit,
thus expanding the spectrum of CDG syndromes. Interest-
ingly, a separate study has identiﬁed a homozygous dele-
tion of a portion of the N33/TUSC3 gene that segregates
withMR in a large consanguineous family, further support-
ing the conclusion that N33/TUSC3 defects are responsible
for autosomal-recessive nonsyndromic MR.14
In the meantime, these results raise the issue of under-
standing how mutations in genes involved in an essential
and ubiquitous cellular process could result in a CNS-re-
stricted phenotype.
It is worth remembering that in Saccharomyces cerevisae,
two distinct isoforms of OTase exist, only differing by the
inclusion of either Ost3p or Ost6p.15,16 Neither Ost3p
nor Ost6p is absolutely required for OTase activity. Indeed,
disruption of either yeast Ost3 or Ost6 genes only caused
a moderate hypoglycosylation phenotype, whereas the
double Dost3Dost6 mutation led to a severe N-glycosyla-
tion defect.12 Moreover, when overexpressed, they could
displace each other, suggesting a dynamic regulation of
the complex.12 Our data suggest that it might also be the
case in human, at least in ﬁbroblasts cells, where IAP could
functionally compensate for the lack of N33/TUSC3 pro-
tein, thus resulting in a normal N-glycosylation in all but
neuronal cells.
Alternatively, the two proteins could also be involved in
the glycosylation of a subset of proteins essential for
normal brain function. This hypothesis is further sup-
ported by the data from B. Schultz and colleagues, who
demonstrated that Ost3p and Ost6p subunits may deter-
mine, to some extent, the substrate speciﬁcity of OTase
complexes (personal communication). Indeed, on the
basis of a multidisciplinary approach, this group has dem-
onstrated that in yeast, Ost3p and Ost6p have disulﬁde
reductase and peptide-binding activities, which modulate
the oxidative folding of speciﬁc glycoproteins, thereby al-
lowing glycosylation of deﬁned acceptor sites. In addition,
their results demonstrate that each protein has distinct site
speciﬁcity, because different sites were underglycosylated
in Ost3 or Ost6 yeast mutants. Given that most N-glycosyl-1156 The American Journal of Human Genetics 82, 1150–1157, Mayation sites do not require reductase activity, these data are
consistent with the absence of a hypoglycosylation pheno-
type of standard glycoproteins observed in patients and
point to a speciﬁc hypoglycosylation of proteins that are
required for normal higher-brain functions.
Cognitive dysfunction is generally regarded as the conse-
quence of a defect in synapse formation and plasticity,
especially in the postnatal stage, during learning and
acquisition of intellectual performance and emotional
behavior. Some evidence supports a close link between
long-term potentiation (LTP) and memory storage.17,18
Along these lines, it is worth remembering that disruption
of N-glycosylation by speciﬁc inhibitors, such as Tunica-
mycin or Swainsonine, had a direct effect on transition
of short-term potentiation into a long-lastingmaintenance
of hippocampal LTP.19 Further studies will hopefully clarify
the nature of the speciﬁc carbohydrate structure and the
identity of the proteins carrying such plasticity-relevant
structures. Yet, the involvement of L1 and neural cell-adhe-
sion molecules (L1CAM and NCAM) is already supported
by several observations, and polysialic acid (PSA) modiﬁca-
tion of NCAM supports the critical role of glycosylation in
synaptic plasticity and memory consolidation.20–23
Furthermore, in brain, PSA is attached to NCAM in a devel-
opmentally regulated manner. PSA-NCAM is associated
with morphogenetic changes during development (cell
migration, synaptogenesis), whereas PSA-NCAM is low in
adult brain except in regions with a high degree of plastic-
ity (hippocampus, hypothalamus, olfactory bulb).24,25 PSA
has a high negative-charge density, which might decrease
adhesion strength of cell interactions26 and be needed
for synapse remodeling. Facilitating synaptic plasticity in-
duces formation and stabilization of a long-lasting mem-
ory trace. Finally, mutations in L1CAM are associated
with neurodevelopmental disorders including X-linked
hydrocephalus and MR, and several amino acid substitu-
tions identiﬁed in patients have been shown to alter the
glycosylation pattern of this protein.27
In conclusion, the results reported here emphasize the
crucial role of OTase activity in higher-brain function
and expand the ﬁeld of the pathophysiology of mental
retardation.
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(IGOLD), http://goldstudy.cimr.cam.ac.uk/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/OMIM/
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